Abstract
Background Self-reporting digital applications provide a way of remotely monitoring and managing patients with chronic conditions in the community. Leveraging the data collected by these applications in prognostic models could provide increased personalisation of care and reduce the burden of care for people who live with chronic conditions. This study evaluated the predictive ability of prognostic models for prediction of acute exacerbation events in people with Chronic Obstructive Pulmonary Disease using data self-reported to a digital health application.
Methods Retrospective study evaluating the use of symptom and Chronic Obstructive Pulmonary Disease assessment test data self-reported to a digital health application (myCOPD) in predicting acute exacerbation events. We include data from 2,374 patients who made a total of 68,139 self-reports. We evaluated the degree to which the different variables self-reported to the application are predictive of exacerbation events and developed both heuristic and machine-learnt models to predict whether the patient will report an exacerbation event within three days of self-reporting to the application. The model’s predictive ability was evaluated on self-reports from an independent set of patients.
Findings Users self-reported symptoms and standard Chronic Obstructive Pulmonary Disease assessment tests display correlation with future exacerbation events. Both a baseline model (AUROC 0.655 (95 % CI: 0.689-0.676)) and a machine-learnt model (AUROC 0.727 (95 % CI: 0.720-0.735)) showed moderate ability in predicting exacerbation events occurring within three days of a given self-report. While the baseline model obtained a fixed sensitivity and specificity of 0.551 (95 % CI: 0.508-0.596) and 0.759 (95 % CI: 0.752-0.767) respectively, the sensitivity and specificity of the machine-learnt model can be tuned by dichotomizing the continuous predictions it provides with different thresholds.
Interpretation Data self-reported to healthcare applications designed to remotely monitor patients with Chronic Obstructive Pulmonary Disease can be used to predict acute exacerbation events with moderate performance. This could increase personalisation of care by allowing pre-emptive action to be taken to mitigate the risk of future exacerbation events. It is plausible future studies could improve the accuracy of these models by either the inclusion of symptom information recorded with greater granularity or including variables not considered in our study, for example vital signs, information on activity, local environmental data, and lifestyle information.
Funding This project was funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 780495 BigMedilytics.
Competing Interest Statement
TMAW is Chief Science Officer and Co-Founder of mymealth, the developer of the myCOPD application. AB is a Senior Research Nurse and Clinical Trial Manager at mymhealth. All other authors declare no competing interests.
Funding Statement
This project was funded by the European Union's Horizon 2020 research and innovation programme under grant agreement No 780495.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This work received ethics approval from the University of Southampton's Faculty of Engineering and Physical Science Research Ethics Committee (ERGO/FEPS/52137) and was reviewed by the University of Southampton Data Protection Impact Assessment panel (DPIA 0045), with the decision to support the research.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data will be made available upon reasonable request to persons with a university affliation. Requestors will need appropiate data protection, governance, and ethical review in place.
